News Main Page
Email A Friend
June 19, 2019
California Workers’ Compensation Appeals Board Posts Proposed Updated Rules of Practice and Procedure for Public Comment
June 18, 2019
California’s Division of Workers’ Compensation to Revise Independent Medical Reviews (IMR), Independent Bill Reviews (IBR) Requests for Proposal
June 13, 2019
Paul Turley, D.C. To Testify In Dr. Uwaydah Criminal Organization Case In L.A. Judge Concerned With Turley's Proffer Stating Uwaydah Controls Everything From Lebanon.
June 13, 2019
California Division of Workers’ Compensation Posts Adjustments to Official Medical Fee Schedule (Physician Services / Non-Physician Practitioner Services)
|California’s Division of Workers’ Compensation Posts Proposed Amendments to Pharmaceutical Fee Schedule to Online Forum for Public Comment|
By Lonce Lamonte and the California Department of Industrial Relations' Newsline - September 27, 2018
The Division of Workers’ Compensation (DWC) has posted proposed amendments to the Pharmaceutical Fee Schedule to its online forum where members of the public may review and comment on the proposal.
Under the California Labor Code, the fee schedule for pharmaceuticals is based primarily upon the Medi-Cal pharmacy payment system. Medi-Cal is now implementing a revised payment methodology approved by the Centers for Medicare and Medicaid Services (CMS). Background information on the Medi-Cal changes can be reviewed on the Department of Health Care Services (DHCS) Pharmacy Reimbursement Project web page. Due to requirements of federal law, the DHCS will implement Medi-Cal pharmacy fee schedule changes retroactively to April 1, 2017. For workers’ compensation, fee schedule changes will not be retroactive; the draft regulations propose that the new methodology become effective for pharmaceuticals dispensed on or after January 1, 2019.
The following regulation changes are proposed to implement Labor Code section 5307.1 and to align the fee schedule with the new Medi-Cal system:
Elimination of the Average Wholesale Price (AWP) minus 17 percent as a benchmark for the drug ingredient;
Revised methodology for payment of the drug ingredient, which sets the maximum at the lower of the following:
National Drug Acquisition Cost (NADAC) or Wholesale Acquisition Cost (WAC) for drugs lacking a NADAC price;
Federal Upper Limit;
Maximum Allowable Ingredient Cost (MAIC);
Usual and Customary Charge;
Adoption of the revised two-tier Medi-Cal dispensing fee structure for pharmacies (which increases the dispensing fee from the current $7.25 to $10.05, or to $13.20 for those pharmacies listed by Medi-Cal as eligible for the higher fee);
Rules addressing fees for compounded drugs and repackaged drugs.
The forum can be found on the DWC forums web page under “current forums.” Comments will be accepted on the forum until Monday, October 8.
# # #
email@example.com, Lonce Lamonte, journalist, in conjunction with the California Department of Industrial Relations' Newsline.